| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/14/2023 | MedTech Acquisition Corp | | Grant | Employee Stock Option (right to buy) | 172.5k | $11.51 | $2M | | 08/14/2023 |
| 06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 20.5k | $29.02 | $594.9k | | 06/16/2023 |
| 06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 40k | $19.00 | $760k | | 06/16/2023 |
| 06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Common Stock | 2.1k | $0.00 | $0 | | 06/16/2023 |
| 06/07/2023 | Omega Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 18.1k | $8.39 | $152k | | 06/07/2023 |
| 05/31/2023 | Kura Oncology, Inc. | KURA | Grant | Option to purchase common stock | 26k | $13.32 | $346.3k | | 05/31/2023 |
| 05/19/2023 | Prometheus Biosciences, Inc. | RXDX | Grant | Common Stock | 2.1k | $0.00 | $0 | | 05/19/2023 |
| 06/21/2022 | Kura Oncology, Inc. | KURA | Grant | Option to purchase common stock | 23k | $14.84 | $341.3k | | 06/21/2022 |
| 06/08/2022 | Omega Therapeutics, Inc. | | Grant | Option (Right to Buy) | 18.1k | $3.31 | $60k | | 06/08/2022 |
| 05/19/2022 | Prometheus Biosciences, Inc. | RXDX | Grant | Stock Option (Right to Buy) | 20.5k | $29.02 | $594.9k | | 05/19/2022 |
| 06/22/2021 | Kura Oncology, Inc. | KURA | Grant | Option to purchase common stock | 23k | $21.54 | $495.4k | | 06/22/2021 |
| 03/11/2021 | Prometheus Biosciences, Inc. | RXDX | Grant | Stock Option (Right to Buy) | 40k | $19.00 | $760k | | 03/11/2021 |
| 01/11/2021 | Coherus BioSciences, Inc. | CHRS | Grant | Stock Option (Right to Buy) | 20k | $17.58 | $351.6k | | 01/11/2021 |
| 06/24/2020 | Kura Oncology, Inc. | KURA | Grant | Option to purchase common stock | 23k | $17.97 | $413.3k | | 06/24/2020 |
| 06/22/2020 | Coherus BioSciences, Inc. | CHRS | Sale | Common Stock, $0.0001 par value | 55k | $17.58 | $966.8k | | 06/22/2020 |
| 06/22/2020 | Coherus BioSciences, Inc. | CHRS | Exercise | Stock Option (Right to Buy) | 15k | $2.50 | $37.5k | | 06/22/2020 |
| 06/22/2020 | Coherus BioSciences, Inc. | CHRS | Exercise | Stock Option (Right to Buy) | 20k | $10.05 | $201k | | 06/22/2020 |
| 06/22/2020 | Coherus BioSciences, Inc. | CHRS | Exercise | Stock Option (Right to Buy) | 20k | $12.37 | $247.4k | | 06/22/2020 |
| 06/18/2020 | ALIMERA SCIENCES INC | ALIM | Grant | Stock Option (Right to Buy) | 3.3k | $6.70 | $22.3k | | 06/18/2020 |
| 01/10/2020 | Coherus BioSciences, Inc. | CHRS | Grant | Stock Option (Right to Buy) | 20k | $17.73 | $354.6k | | 01/10/2020 |
| 06/25/2019 | Kura Oncology, Inc. | KURA | Grant | Option to purchase common stock | 13k | $19.55 | $254.2k | | 06/25/2019 |
| 06/19/2019 | ALIMERA SCIENCES INC | ALIM | Grant | Stock Option (Right to Buy) | 50k | $0.92 | $46k | | 06/19/2019 |
| 01/11/2019 | Coherus BioSciences, Inc. | CHRS | Grant | Stock Option (Right to Buy) | 20k | $12.37 | $247.4k | | 01/11/2019 |
| 11/06/2018 | Kura Oncology, Inc. | KURA | Grant | Option to purchase common stock | 30k | $11.55 | $346.5k | | 11/06/2018 |
| 11/06/2018 | Kura Oncology, Inc. | KURA | Grant | Option to purchase common stock | 7.6k | $11.55 | $87.6k | | 11/06/2018 |
| 06/19/2018 | ALIMERA SCIENCES INC | ALIM | Grant | Employee Stock Option (Right to Buy) | 40k | $0.86 | $34.4k | | 06/19/2018 |
| 02/01/2018 | Coherus BioSciences, Inc. | CHRS | Grant | Stock Option (Right to Buy) | 20k | $10.05 | $201k | | 02/01/2018 |
| 05/17/2017 | Coherus BioSciences, Inc. | CHRS | Grant | Stock Option (Right to Buy) | 20k | $23.80 | $476k | | 05/17/2017 |
| 05/09/2017 | NOVELION THERAPEUTICS INC. | NVLNF | Payment of Exercise | Common Shares | 2.2k | $9.42 | $21.2k | | 05/09/2017 |
| 05/09/2017 | NOVELION THERAPEUTICS INC. | NVLNF | Exercise | Restricted Stock Units | 6.6k | $0.00 | $0 | | 05/09/2017 |
| 12/22/2016 | NOVELION THERAPEUTICS INC. | NVLNF | Grant | Stock Option (right to buy) | 323.5k | $0.00 | $0 | | 12/22/2016 |
| 05/24/2016 | Coherus BioSciences, Inc. | CHRS | Grant | Stock Option (Right to Buy) | 10k | $18.28 | $182.8k | | 05/24/2016 |
| 12/14/2011 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 500 | $54.33 | $27.2k | | 12/14/2011 |
| 12/14/2011 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 300 | $54.33 | $16.3k | | 12/14/2011 |
| 12/14/2011 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 2.5k | $54.33 | $135.8k | | 12/14/2011 |
|